Interesting IBM Put And Call Options For November 2026

At IBM's current price of $304.67, a $300 put is bid at $30.85, implying a net cost basis of $269.15 if sold-to-open and a 60% probability to expire worthless; the premium equates to a 10.28% return (11.51% annualized). A covered-call at the $315 strike is bid at $32.50, which would deliver a 14.06% total return if called at the November 2026 expiry or a 10.67% premium boost (11.94% annualized) if it expires worthless; the market assigns ~46% odds of expiring worthless. Implied volatility on both contracts is ~33% versus a 12-month trailing volatility of ~30%, and the piece frames these figures as option-income ideas rather than fundamental corporate news.

Analysis

Market structure: The current chain favors option sellers — retail and option-writing desks collect ~10–11% one‑year yield (put yieldBoost 11.5% a.r.; covered call 11.9% a.r.) vs IBM spot $304.67. That benefits income funds and dealers who warehouse delta; it hurts directional longs if assignment forces buy at $300 or caps upside at $315. With IV ~33% vs realized ~30% the market is slightly premiumed but not extreme, so skew-driven flows (sell puts, sell calls) are the marginal liquidity drivers.

Risk assessment: Tail risks include a >20% earnings shock or dividend cut that could push IBM below ~$245 (catastrophic for naked cash-secured puts) and a macro slowdown that compresses services revenues; probability low but impact high. Near-term catalysts: next 2–3 quarterly earnings and any large customer/cloud contract cadence; monitor IV moves >+50% (stress). Over 6–12+ months, structural outcomes depend on hybrid-cloud/AI adoption — outcomes range from modest re-rating to prolonged stagnation.

Trade implications: Tactical income play — establish cash‑secured sell-to-open IBM Nov‑2026 $300 put size = 1–2% portfolio cash exposure per contract (require $30k notional per contract), target effective basis $269.15; close or hedge if IBM < $275 or IV spikes >+15 pts. Alternative: buy 100 IBM and sell Nov‑2026 $315 covered call to lock ~14% gross to Nov‑26; if bullish, prefer covered call to retain upside beyond $315 by buying back/rolling above $330. Risk‑defined alternative: sell $300/$270 put credit spread to limit assignment risk.

Contrarian angle: The market under-weights asymmetric upside from a successful AI/cloud re-rating — a move to $360+ would make covered-call sellers look short; conversely consensus underprices assignment risk (60% put OTM). Historical parallels: legacy tech re-ratings have taken 12–36 months; don’t treat ~11% yield as free lunch. Unintended consequence: concentrated put-selling could amplify downside on a negative print as dealers hedge delta by selling shares.

Key Decisions for Investors

• Sell 1 Nov‑2026 IBM $300 cash‑secured put per $30,000 notional (collect $3,085). Size at 1–2% portfolio; plan: buy‑to‑close if IBM < $275 or IV > 45% or 30% loss of premium. Target hold/window: enter within 7 trading days to capture current IV; roll only if assignment probability exceeds 70%.
• Buy 100 IBM shares and sell 1 Nov‑2026 $315 covered call (collect $3,250) for investors wanting equity plus yield. Position sizing 1–3% portfolio; if IBM > $330 before expiry, buy back/roll up to capture upside; if IBM < $295 at next earnings, consider closing and redeploying cash.
• If concerned about assignment, sell a defined‑risk put spread: sell Nov‑2026 $300 / buy $270 for net credit (~reduce downside). Limit position to 0.5–1% portfolio and close/roll if spread widens beyond 2x initial width or IBM < $275.
• Avoid outright long‑only levered bets on IBM until next two earnings prints; instead favor income/backed equity (cash‑secured puts or covered calls). Monitor IV vs realized: add to short‑premium exposure only if IV premium persists >= +5 vol pts over realized for >10 trading days.